Ascentage Pharma gets Chinese approval for solid tumor study
Ascentage Pharma says its novel inhibitor of the embryonic ectoderm development (EED) protein, APG-5918, has…
November 10, 2022 - 3 minutes
Ascentage Pharma says its novel inhibitor of the embryonic ectoderm development (EED) protein, APG-5918, has…
Ascentage Pharma has released results from a phase I study of the investigational inhibitor of…